The $19.2 billion risk transfer transaction reduces MetLife's risk exposure, making the company more attractive to investors. Additionally, the increased share repurchase authorization to $4 billion signals the company's confidence in its financial position and future prospects, which is likely to boost investor sentiment and drive the stock price up in the short term.